Drug discovery

#AI #Drug discovery #Generative AI #Machine learning

Generative AI and drug discovery: webinar

The webinar ‘Generative AI: Turning drug discovery into a technological pursuit’ supported by Thermo Fisher Scientific and presented by Generate:Biomedicines will be free to attend on 12 October 9am EDT / 2pm BST / 3pm CEST. The webinar, hosted by DDW, will feature the expertise of Adam Root, Vice President,… Read More

#News

Cancer research
#Cancer research #DDW Turning Science into Business Summit #Drug discovery #Oncology #Taconic #Webinar

DDW Turning Science Into Business Summit: Cancer research opportunities and advances

Join DDW for its Turning Science into Business Summit: Cancer research opportunities and advances. This free online event will be hosted by DDW and is sponsored by Taconic Biosciences. The 2-hour Summit will outline areas of advancement and opportunity in the cancer research market and will consist of presentations from… Read More

Webinar date:
Sponsored by Taconic Biosciences
#Webinars

#AI / data analytics / healthtech / informatics #Cloud computing #Drug discovery #Webinar

On-demand webinar: A data-driven approach to drug discovery

Watch this new webinar to embark on an in-depth journey through the pivotal Make-Test-Decide Workflow, where collaboration and data-driven decisions play a paramount role in the intricate landscape of drug discovery. This on-demand webinar from Revvity Signals shows how cloud implementation fosters accessibility and collaboration, revolutionising research across locations and… Read More

Webinar date:
Brought to you by Revvity Signals
#News

#AI / data analytics / healthtech / informatics #Cloud computing #Drug discovery #Webinar

From lead optimisation to drug candidate triage: A data-driven approach to drug discovery

Embark on an in-depth journey through the pivotal Make-Test-Decide Workflow, where collaboration and data-driven decisions play a paramount role in the intricate landscape of drug discovery. This on-demand webinar shows how cloud implementation fosters accessibility and collaboration, revolutionising research across locations and companies. This presentation illustrates: The use of the… Read More

Webinar date:
Brought to you by Revvity Signals
#Webinars

AI and lab automation
#Artificial intelligence (AI) #Benchling #Drug discovery #Lab automation #Proscia #Webinar

Key benefits and latest innovations in AI and lab automation

Hosted by DDW and co-sponsored by Benchling and Proscia, “AI and Lab Automation: What are the key benefits and latest innovations?” will be free to attend on 10 October at 7AM PDT / 10AM EST / 3PM BST / 4PM CET. Join this free webinar to learn… Read More

#News

#CDMO #Collaboration #CRO #Drug development #Drug discovery #Guide

Latest Guide: Streamline your drug development pathway

In pharmaceutical development, collaborating with multiple Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Organisations (CROs) poses potential hurdles – from poor communication to delays, errors, and inconsistent feedback during the progression from preclinical to formulation optimisation and clinical trials. Download this new guide from SGS… Read More

#News

#CDMO #Collaboration #CRO #Drug development #Drug discovery #Guide

Streamline your drug development pathway

In pharmaceutical development, collaborating with multiple Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Organisations (CROs) poses potential hurdles – from poor communication to delays, errors, and inconsistent feedback during the progression from preclinical to formulation optimisation and clinical trials. Download this SGS guide to discover: How to collaborate… Read More

#Intelligence #Resources

#Antibodies #Antibody drug conjugate (ADC) #CAR-T #Drug development #Drug discovery #Immunotherapy #Monoclonal antibodies

New DDW Highlights podcast: 2 October 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Immunotherapy has taken centre stage this week, with several announcements relating to… Read More

#News

DDW Neuroscience Guide
#Drug development #Drug discovery #Guide #Neurology #Neuroscience #Precision psychiatry

Unlocking neuroscience drug discovery

DDW has published the latest addition to its Guide Series, ‘Unlocking neuroscience drug discovery’. It covers the way the neuroscience sector is overcoming drug discovery challenges, advances in neuroscience and the era of precision neuroscience. Download to find out: Neuroscience drug discovery advances and challenges and how breakthroughs in this… Read More

#DDW eBooks #DDW Guides

Scientific research
#Drug discovery #In vitro #mRNA #Webinar

Scaling up in vitro transcription: Key results and considerations

In vitro transcription (IVT) can be a complicated reaction. Scaling up this process requires a good understanding of the various reaction parameters that need to be optimised and controlled to give the best result in terms of mRNA yields and quality. In this presentation, a review of the results from scaling… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#Webinars

Biologics research
#Biologics #Biologics / Biotechnology #Drug discovery #Infographic

Characterisation of candidates during biologic development

Download the new Infographic from NanoTemper: ‘Stability assessment of biologics during early development workflows‘. During early development of biologics, there are a large number of attributes researchers evaluate, but some of the most common centre around stability – asking if a biologic is well-folded, active and pure… Read More

#News

#Biologics #Biologics / Biotechnology #Drug discovery #Infographic

Stability assessment of biologics during early development workflows

During early development of biologics, there are a large number of attributes researchers evaluate, but some of the most common centre around stability – asking if a biologic is well-folded, active and pure in its buffer, and whether it remains that way over time. Biophysical characterisations are valuable for providing… Read More

#Intelligence #Resources

#Antibodies #Antibody drug conjugate (ADC) #CAR-T #Drug development #Drug discovery #Immunotherapy #Monoclonal antibodies

This week in drug discovery (25-29 September)  

News round-up for 25-29 September by DDW Digital Content Editor Diana Spencer. Immunotherapy has taken centre stage this week, with several announcements relating to regulatory approval, investment and research results for antibody and CAR-T therapies, perhaps most significantly, encouraging early-stage data for the first in vivo… Read More

#News

Antibiotics
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Bacteria #Drug discovery

Antimicrobial resistance: Tackling the ‘silent pandemic’

Diana Spencer speaks to Christopher Reid, Professor of Biological and Biomedical Sciences at Bryant University, in Rhode Island, US, to understand the issue of antimicrobial resistance, why there are so few new antibiotics in development and where the drug discovery opportunities can be found. The scale of the… Read More

#Exclusive Content

#Assay #Biologics / Biotechnology #Biopharma #Diversity #DNA #Drug development #Drug discovery #Gene sequencing #Ingredients / APIs / Fine chemicals #Synthetic biology #Women in Discovery #Women in STEM

New podcast: Overcoming different barriers in drug discovery

This is the latest episode of the free DDW narrated podcast, “Overcoming different barriers in drug discovery”, which covers three articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Addressing the challenge of salt forms in drug discovery”, “… Read More

#News